PHT's markets include pharmas experimenting with new drugs (e.g. randomised clinical trials) and the effectiveness of listed drugs, as well as healthcare professionals and organizations practicing clinical knowledge management, including evidence-based medicine, decision support and electronic data capture.

In sum, PHT supports effective experimentation, study monitoring and knowledge management with a low cost and time solution. Its networks and parameter driven approach allow experiments and questions to be explored with minimal effort. Its integration capability with local networks enables a seamless user experience at the desktop – all up delivering significant user satisfaction and a cost-effective solution to healthcare organisations and product manufacturers. ( www.PHT.org.au )

Several years were spent investing in research, development and eventual commercialisation of the system. In 2007 the National Health Sciences Centre sold the PHT system intellectual property through a trade and development agreement to Eonica Pty Ltd. Eonica has since licensed the software to Treonic Pty Ltd for further commercialisation. It is understood that Treonic has made considerable sales of the software to about 15 different health organisations involved in clinical trials.  www.Treonic.com

A copy of the PHT system software is also protected under copyright laws.

www.treonic.com